ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 266763 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 266763; 2) Community: the network communities that were significantly associated with the response to NSC 266763; 3) Molecule: the relationships between components within communities and NSC 266763; 4) MDR: the compounds that were significantly associated with the NSC 266763.

NSC Compound Enrichment Correlation
NSC 717953 Null 0.0401206532535671 0.030056935
NSC 720134 Null 0.0401206532535671 -0.014246313
NSC 726578 Null 0.0401206532535671 0.39905638
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.0401206532535671 -0.0077089193
NSC 756375 GW811761X 0.0401206532535671 0.17126636
NSC 174121 Methotrexate Derivative 0.0420893367628867 -0.073159402
NSC 324979 Copper, chloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydrazidato]-, (SP-4-3)- 0.0420893367628868 -0.05411258
NSC 626433 3-Nitro-5-formylisoxazole 0.0420893367628868 0.01141688
NSC 632791 Platinum, dichloro[(methylsulfinyl)phenyl-S](quinoline-N)-, (SP-4-1) 0.0420893367628868 0.071475947
NSC 646604 Null 0.0420893367628868 0.2595084
Total:19  Current:15    [First] [Prev] [Next] [Last]